Company Overview and News

Apollo Global Management's (APO) CEO Leon Black on Q3 2017 Results - Earnings Call Transcript

2017-11-01 seekingalpha
Good morning, and welcome to Apollo Global Management’s 2017 Third Quarter Earnings Conference Call. During today’s presentation all callers will be placed in a listen-only mode and following management’s prepared remarks the conference will be open for questions. This conference call is being recorded.

NN Group: A Deep Value Play With More Than 50% Upside

2017-09-20 seekingalpha
It has recently completed a merger with its competitor Delta Lloyd, a combination that is expected to generate significant cost and capital synergies in the next few years.

Generali puts $50 billion German life portfolio on block: sources

2017-07-12 reuters
FRANKFURT/LONDON (Reuters) - Italy's Generali (GASI.MI) has put its 44 billion euro ($50 billion) German life insurance portfolio up for sale as it restructures in Europe, sources close to the matter said.

Anbang chairman’s mysterious absence adds to intrigue

2017-06-15 themalaymailonline
Chairman of Anbang Insurance Group Wu Xiaohui attends the China Development Forum in Beijing, China, March 18, 2017. — Reuters picBEIJING, June 15 — Only a year ago he was hailed as one of the boldest dealmakers in China.

Half-year Report

2017-05-24 londonstockexchange
The Directors announce the unaudited Half-Yearly Report for the half year ended 31 March 2017 as follows:

Holding(s) in Company

2017-04-10 londonstockexchange

Delta Lloyd takeover gets clearance

2017-04-07 northern-observer
Dutch insurer NN Group reported it had been given clearance for the takeover of financial group Delta Lloyd from the relevant authorities.

The Nest Egg Dividend Portfolio: Adding More Names To The Portfolio

2017-04-06 seekingalpha
It has been more than a week since the first positions in the Nest Egg Portfolio (or 'NEPO') were initiated, so it's about time to add new companies to this virtual 100,000 EUR portfolio.

Annual Financial Report

2017-03-20 londonstockexchange
A copy of the Company's Annual Report and Financial Statements for the period from 7 October 2015 (date of incorporation) to 31 December 2016 will shortly be available to view and download from the Company's website, Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.

Chairman of China’s Anbang bullish on Europe’s ‘cheap assets’

2017-03-18 themalaymailonline
Chairman of Anbang Insurance Group Wu Xiaohui attends the China Development Forum in Beijing, China, March 18, 2017. — Reuters picBEIJING, March 18 — The chairman of China’s privately-held Anbang Insurance Group said at the China Development Forum today he is bullish on investing in Europe despite great uncertainty over issues including refugees, economic challenges and rising populism.

Chairman of China's Anbang bullish on Europe's "cheap assets"

2017-03-18 reuters
BEIJING The chairman of China's privately-held Anbang Insurance Group said at the China Development Forum on Saturday he is bullish on investing in Europe despite great uncertainty over issues including refugees, economic challenges and rising populism.

Delta Lloyd refocuses in 2016

2017-02-23 northern-observer
Financial group Delta Lloyd reported it was focusing on capital, performance and customer satisfaction as it works toward being combined with the NN Group.

Delta Lloyd all cash offer by NN Group

2017-02-02 northern-observer
Financial group Delta Lloyd announced the takeover offer by NN Group would be all cash at €5.40 per share, representing a total consideration of €2.5 billion for the business.

Dutch tycoon de Mol plans counter-offer for media group TMG

2017-01-23 reuters
Dutch billionaire John de Mol plans to make a bid for Telegraaf Media Group (TMG) (TLGNc.AS) that values the Dutch newspaper publisher at 273 million euros ($293 million), potentially sparking a bid battle with a rival suitor.

Delta Lloyd agrees takeover price

2017-01-02 northern-observer
Financial group Delta Lloyd announced it had agreed a recommended takeover price of €5.40 per share with Euronext listed Dutch insurer NN Group valuing Delta Lloyd at €2.5 billion.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

14h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

14h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...